These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31581569)

  • 1. Growth Differentiation Factor-15 (GDF-15) is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients.
    Nakajima T; Shibasaki I; Sawaguchi T; Haruyama A; Kaneda H; Nakajima T; Hasegawa T; Arikawa T; Obi S; Sakuma M; Ogawa H; Toyoda S; Nakamura F; Abe S; Fukuda H; Inoue T
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31581569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between serum GDF-15, myostatin, and sarcopenia in cardiovascular surgery patients.
    Nishikawa R; Fukuda T; Haruyama A; Shibasaki I; Yamaguchi S; Arikawa T; Obi S; Amano H; Yagi H; Sakuma M; Abe S; Fukuda H; Toyoda S; Nakajima T
    Int J Cardiol Heart Vasc; 2022 Oct; 42():101114. PubMed ID: 36071948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the serum GDF-15 concentration and muscle function in female patients receiving aortic valve replacement (TAVR, SAVR): Comparison with healthy elderly female subjects.
    Fukuda T; Nakajima T; Yazawa H; Hirose S; Yokomachi J; Kato T; Nishikawa R; Koshiji N; Tokura M; Nasuno T; Nishino S; Obi S; Shibasaki I; Kanaya T; Nakamura F; Fukuda H; Abe S; Sakuma M; Toyoda S
    Int J Cardiol Heart Vasc; 2022 Jun; 40():101032. PubMed ID: 35495578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum leptin and adiponectin concentrations with echocardiographic parameters and pathophysiological states in patients with cardiovascular disease receiving cardiovascular surgery.
    Sawaguchi T; Nakajima T; Haruyama A; Hasegawa T; Shibasaki I; Nakajima T; Kaneda H; Arikawa T; Obi S; Sakuma M; Ogawa H; Takei Y; Toyoda S; Nakamura F; Abe S; Fukuda H; Inoue T
    PLoS One; 2019; 14(11):e0225008. PubMed ID: 31703113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological Role of Serum Growth Differentiation Factor-15 (GDF-15) Level and Iron Metabolism in Community-Dwelling Older Adults.
    Fukuda T; Yazawa H; Nishikawa R; Tokoi S; Kayashima R; Kono K; Sakuma M; Abe S; Toyoda S; Nakajima T
    Cureus; 2024 May; 16(5):e60422. PubMed ID: 38883134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum growth differentiation factor-15 with eGFR and hemoglobin in healthy older females.
    Yazawa H; Fukuda T; Kaneda H; Waku R; Sakuma M; Matsumoto A; Toyoda S; Abe S; Nakamura F; Inoue T; Nakajima T
    Int J Cardiol Heart Vasc; 2020 Dec; 31():100651. PubMed ID: 33134478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological roles of the serum acylcarnitine level and acylcarnitine/free carnitine ratio in patients with cardiovascular diseases.
    Nakajima T; Fukuda T; Shibasaki I; Obi S; Sakuma M; Abe S; Fukuda H; Toyoda S; Nakajima T
    Int J Cardiol Heart Vasc; 2024 Apr; 51():101386. PubMed ID: 38515869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Plasma Growth and Differentiation Factor 15 Is Associated With Slower Gait Speed and Lower Physical Performance in Healthy Community-Dwelling Adults.
    Semba RD; Gonzalez-Freire M; Tanaka T; Biancotto A; Zhang P; Shardell M; Moaddel R; ; Ferrucci L
    J Gerontol A Biol Sci Med Sci; 2020 Jan; 75(1):175-180. PubMed ID: 30874790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Plasma Levels of Growth Differentiation Factor-15 and Renal Function in the Elderly: Korean Frailty and Aging Cohort Study.
    Kim JS; Kim S; Won CW; Jeong KH
    Kidney Blood Press Res; 2019; 44(3):405-414. PubMed ID: 31163432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum concentrations of growth differentiation factor-15 and their association with Crohn's disease and a low skeletal muscle index.
    Yamamoto H; Takeshima F; Haraguchi M; Akazawa Y; Matsushima K; Kitayama M; Ogihara K; Tabuchi M; Hashiguchi K; Yamaguchi N; Miyaaki H; Kondo H; Nakao K
    Sci Rep; 2022 Apr; 12(1):6591. PubMed ID: 35449185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Serum GDF-15, Endothelin-1 Levels, and Intraoperative Factors as Short-Term Operative Risks for Patients Undergoing Cardiovascular Surgery.
    Kato T; Nakajima T; Fukuda T; Shibasaki I; Hasegawa T; Ogata K; Ogawa H; Hirota S; Ohashi H; Saito S; Takei Y; Tezuka M; Seki M; Kuwata T; Sakuma M; Abe S; Toyoda S; Inoue T; Fukuda H
    J Clin Med; 2021 May; 10(9):. PubMed ID: 34063283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative plasma growth-differentiation factor-15 for prediction of acute kidney injury in patients undergoing cardiac surgery.
    Heringlake M; Charitos EI; Erber K; Berggreen AE; Heinze H; Paarmann H
    Crit Care; 2016 Oct; 20(1):317. PubMed ID: 27717384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of growth differentiation factor-15 as a predictor of cardiovascular surgery outcomes: Current research and future directions.
    Shibasaki I; Otani N; Ouchi M; Fukuda T; Matsuoka T; Hirota S; Yokoyama S; Kanazawa Y; Kato T; Shimizu R; Tezuka M; Takei Y; Tsuchiya G; Saito S; Konishi T; Ogata K; Toyoda S; Fukuda H; Nakajima T
    J Cardiol; 2024 Mar; 83(3):211-218. PubMed ID: 37648079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
    Bidadkosh A; Lambooy SPH; Heerspink HJ; Pena MJ; Henning RH; Buikema H; Deelman LE
    Diabetes Care; 2017 Jun; 40(6):784-792. PubMed ID: 28341782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-operative growth differentiation factor 15 as a novel biomarker of acute kidney injury after cardiac bypass surgery.
    Guenancia C; Kahli A; Laurent G; Hachet O; Malapert G; Grosjean S; Girard C; Vergely C; Bouchot O
    Int J Cardiol; 2015 Oct; 197():66-71. PubMed ID: 26113476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth differentiation factor-15 as a biomarker for sarcopenia in aging humans and mice.
    Kim H; Kim KM; Kang MJ; Lim S
    Exp Gerontol; 2020 Dec; 142():111115. PubMed ID: 33069782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic profiling shows pre-existing mitochondrial dysfunction contributes to muscle loss in a model of ICU-acquired weakness.
    Kemp PR; Paul R; Hinken AC; Neil D; Russell A; Griffiths MJ
    J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1321-1335. PubMed ID: 32677363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth differentiation factor 15: a novel risk marker adjunct to the EuroSCORE for risk stratification in cardiac surgery patients.
    Heringlake M; Charitos EI; Gatz N; Käbler JH; Beilharz A; Holz D; Schön J; Paarmann H; Petersen M; Hanke T
    J Am Coll Cardiol; 2013 Feb; 61(6):672-81. PubMed ID: 23391200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of growth differentiation factor 15 with other key biomarkers, functional parameters and mortality in community-dwelling older adults.
    Rothenbacher D; Dallmeier D; Christow H; Koenig W; Denkinger M; Klenk J;
    Age Ageing; 2019 Jul; 48(4):541-546. PubMed ID: 30855645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.